162 related articles for article (PubMed ID: 26296919)
41. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.
Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED
Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of vascular endothelial growth factors A, C and D as indicators of lymphangiogenesis and angiogenesis in invasive and non-invasive urothelial carcinoma bladder.
Khadim MT; Ahmed SA; Khan FA; Ikram A; Shaikh SY
J Pak Med Assoc; 2015 Aug; 65(8):851-6. PubMed ID: 26228330
[TBL] [Abstract][Full Text] [Related]
43. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
44. Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
Chen H; Guan R; Lei Y; Chen J; Ge Q; Zhang X; Dou R; Chen H; Liu H; Qi X; Zhou X; Chen C
BMC Cancer; 2015 Mar; 15():103. PubMed ID: 25884175
[TBL] [Abstract][Full Text] [Related]
45. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
Fukunaga S; Maeda K; Noda E; Inoue T; Wada K; Hirakawa K
Oncology; 2006; 71(3-4):204-11. PubMed ID: 17641542
[TBL] [Abstract][Full Text] [Related]
46. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma.
Baek SK; Jung KY; Lee SH; Woo JS; Kwon SY; Chung EJ; Kim TH; Chae YS
Laryngoscope; 2009 Jul; 119(7):1325-30. PubMed ID: 19444880
[TBL] [Abstract][Full Text] [Related]
48. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
[TBL] [Abstract][Full Text] [Related]
49. Lymphatic vessel density and VEGF-C expression as independent predictors of melanoma metastases.
Špirić Z; Eri Ž; Erić M
J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1653-1659. PubMed ID: 28756123
[TBL] [Abstract][Full Text] [Related]
50. Lymphangiogenesis and biological behavior in pancreatic carcinoma and other pancreatic tumors.
Wang Z; Wu J; Li G; Zhang X; Tong M; Wu Z; Liu Z
Mol Med Rep; 2012 Apr; 5(4):959-63. PubMed ID: 22246595
[TBL] [Abstract][Full Text] [Related]
51. New model of in-situ xenograft lymphangiogenesis by a human colonic adenocarcinoma cell line in nude mice.
Sun JJ; Jing W; Ni YY; Yuan XJ; Zhou HH; Fan YZ
Asian Pac J Cancer Prev; 2012; 13(6):2823-8. PubMed ID: 22938466
[TBL] [Abstract][Full Text] [Related]
52. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
53. Neither expression of VEGF-C/D nor lymph vessel density supports lymphatic invasion as the mechanism responsible for local spread of recurrent salivary pleomorphic adenoma.
Salzman R; Stárek I; Kučerová L; Skálová A; Hoza J
Virchows Arch; 2014 Jan; 464(1):29-34. PubMed ID: 24233153
[TBL] [Abstract][Full Text] [Related]
54. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
55. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
[TBL] [Abstract][Full Text] [Related]
56. Expression of vascular endothelial growth factor-C and the relationship between lymphangiogenesis and lymphatic metastasis in colorectal cancer.
Jia YT; Li ZX; He YT; Liang W; Yang HC; Ma HJ
World J Gastroenterol; 2004 Nov; 10(22):3261-3. PubMed ID: 15484296
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of expression of molecular markers in adenoid cystic cancer of the salivary glands compared with lymph node metastasis: a retrospective study.
Lee SK; Kwon MS; Lee YS; Choi SH; Kim SY; Cho KJ; Nam SY
World J Surg Oncol; 2012 Dec; 10():266. PubMed ID: 23231994
[TBL] [Abstract][Full Text] [Related]
58. [Relation of lymphatic microvessel density detected by monoclonal antibody D2-40 with VEGF-C expression in breast cancer].
Xie XD; Qu SX; Zheng ZD; Song FL; Liu DW
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):356-60. PubMed ID: 18953835
[TBL] [Abstract][Full Text] [Related]
59. The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma.
Voss M; Steidler A; Grobholz R; Weiss C; Alken P; Michel MS; Trojan L
BJU Int; 2009 Jul; 104(1):94-9. PubMed ID: 19500329
[TBL] [Abstract][Full Text] [Related]
60. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]